PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
12-Mar-2020 Major R&D milestones achieved in 2019 and strong clinical activity in 2020 Transgene
12-Mar-2020 Q BioMed Treats its First Patient in Commercial Setting Following Product Launch Q BioMed Inc
12-Mar-2020 Data visualisation tools developed by Zegami will be used by Oxford University for large cardiovascular clinical trials Zegami
12-Mar-2020 New study published in the Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance shows benefit of cystitis service in community pharmacies Boots UK
11-Mar-2020 Bone Therapeutics announces 2019 full year results Bone Therapeutics
11-Mar-2020 Tiziana Life Sciences plc To Expedite Development of its Fully Human Anti-Interleukin-6-Receptor Monoclonal Antibody, a Potential Treatment of Certain Patients Infected with Coronavirus COVID-19 Tiziana Life Sciences plc
11-Mar-2020 BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states BillionToOne
11-Mar-2020 First mental health trust joins collaboration of North East NHS organisations to drive forward digital health technology within the region Health Call
11-Mar-2020 Drugs alone cannot improve diabetes patients’ outcomes GlobalData
11-Mar-2020 Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed Cmed Clinical Research Services
10-Mar-2020 PharmiWeb Launches New Job Board for Pharma & Life Sciences in Australasia PharmiWeb
10-Mar-2020 Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance Kinepict Health Ltd.
10-Mar-2020 Freeline receives Orphan Drug Designation from the European Commission for FLT190 for the treatment of Fabry Disease Freeline
10-Mar-2020 PureTech Affiliate Gelesis Named One of the World’s Most Innovative Companies for 2020 by Fast Company PureTech
10-Mar-2020 Orgenesis Year-End Results, outlines business model and POCare strategy post-Masthercell sale Orgenesis
10-Mar-2020 Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention Pivotal
10-Mar-2020 Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO's 49% joint venture with the SEEK Group. FLU-v is a first-in-class ‘universal’, broad spectrum, standalone, influenza vaccine candidate and the results have now been published in a peer review journal Open Orphan plc
10-Mar-2020 New initiative to give cancer patients easier access to clinical trials and increase patient diversity in research The Christie NHS Foundation Trust and Innovative Trials
09-Mar-2020 Chemotherapy after surgery halves risk of rare kidney cancer coming back The Institute of Cancer Research
09-Mar-2020 Nanoform and Orion collaborate on next-generation drug development Nanoform